Life Science Big News Roundup: BriaCell Doses First Patient in Phase I/IIa Study; PreveCeutical Receives AU$616,802 R&D Tax Incentive Cash Refund; Lexaria Provides Update on R&D Program with Altria

In case you missed it, here is this week’s life science big news roundup.

In case you missed it, here is this week’s life science big news roundup:

Biotech:

To see our previous Life Science Investing Big News Roundups, please click here.

Learn how to invest in life science and medical stocks

 

Read your free starter guide to investing in life science

 

Leave a Reply

Your email address will not be published. Required fields are marked *

  • bitcoinBitcoin (BTC) $ 8,037.77 1.29%
  • ethereumEthereum (ETH) $ 176.38 1.4%
  • rippleXRP (XRP) $ 0.294560 1.71%
  • tetherTether (USDT) $ 1.00 0.07%
  • bitcoin-cashBitcoin Cash (BCH) $ 218.38 2.12%
  • litecoinLitecoin (LTC) $ 53.36 2.74%
  • eosEOS (EOS) $ 2.93 0.54%
  • binancecoinBinance Coin (BNB) $ 18.49 1.35%
  • bitcoin-cash-svBitcoin SV (BSV) $ 87.74 3.54%
  • stellarStellar (XLM) $ 0.063221 0.01%